KIM; Hun-Taek

Patent Applications and Registrations

Patent applications and USPTO patent grants for KIM; Hun-Taek.The latest application filed is for "salt and crystalline form of furopyrimidine compound and pharmaceutical use thereof".

Company Profile

1.19.23

KIM; Hun-Taek - Seongnam-si KR
Kim; Hun-Taek - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Salt And Crystalline Form Of Furopyrimidine Compound And Pharmaceutical Use Thereof App 20220002312 - LEE; Minhee ; et al.	2022-01-06
Fusion protein having factor VII activity Grant 10,696,960 - Song , et al. June 30, 2	2020-06-30
2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors Grant 10,155,763 - Lee , et al. Dec	2018-12-18
Pharmaceutical composition with improved stability containing factor VII fusion protein Grant 9,987,339 - Kim , et al. June 5, 2	2018-06-05
Process for producing and purifying factor VIII and its derivatives Grant 9,926,361 - Song , et al. March 27, 2	2018-03-27
Fusion protein having factor VII activity Grant 9,644,197 - Song , et al. May 9, 2	2017-05-09
Percutaneous absorption preparation containing donepezil, and method for preparing same Grant 9,622,986 - Im , et al. April 18, 2	2017-04-18
Fusion protein having factor IX activity Grant 9,617,328 - Lee , et al. April 11, 2	2017-04-11
Active Ingredient (i) Containing Composition And Method For Preparing Same App 20170049782 - PARK; Jun-sung ; et al.	2017-02-23
Pharmaceutical Composition With Improved Stability Containing Factor Vii Fusion Protein App 20170000861 - KIM; Hong-Kee ; et al.	2017-01-05
Process For Producing And Purifying Factor Viii And Its Derivatives App 20160347819 - Song; In-Young ; et al.	2016-12-01
Gonadotropin releasing hormone receptor antagonists, method for the preparation thereof and pharmaceutical composition comprising the same Grant 9,481,684 - Kim , et al. November 1, 2	2016-11-01
Process for producing and purifying factor VIII and its derivatives Grant 9,441,030 - Song , et al. September 13, 2	2016-09-13
Fusion Protein Havingh Factor Vii Activity App 20160194622 - Song; In-Young ; et al.	2016-07-07
Method of Isolating and Purifying Fusion Protein Comprising Factor VII App 20160060612 - Lee; Ji-Hye ; et al.	2016-03-03
Medicine Having Improved Rivastigmine Stability App 20150250758 - Hwang; Yong-Youn ; et al.	2015-09-10
Gonadotropin Releasing Hormone Receptor Antagonists, Method For The Preparation Thereof And Pharmaceutical Composition Comprising The Same App 20150166558 - Kim; Seon-Mi ; et al.	2015-06-18
Preparation For Percutaneous Absorption Containing Rotigotine App 20150118309 - KIM; Hye-Min ; et al.	2015-04-30
Transdermally Absorbable Preparation Containing Rotigotine App 20150118282 - KIM; Hye-Min ; et al.	2015-04-30
Percutaneous Absorption Preparation Containing Donepezil, And Method For Preparing Same App 20150045749 - Im; Jong-Seob ; et al.	2015-02-12
Fusion Protein Having Factor Ix Activity App 20130296534 - Lee; Min Sun ; et al.	2013-11-07
2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors App 20130245066 - Kim; Dae-Kee ; et al.	2013-09-19
Fusion Protein Having Factor VII Activity App 20130236945 - Song; In-Young ; et al.	2013-09-12
2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors Grant 8,420,685 - Kim , et al. April 16, 2	2013-04-16
2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors Grant 8,410,146 - Lee , et al. April 2, 2	2013-04-02
Process For Producing And Purifying Factor Viii And Its Derivatives App 20100112641 - Song; In-Young ; et al.	2010-05-06
2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 Inhibitors App 20100022535 - Lee; Ju Young ; et al.	2010-01-28
2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors App 20080319012 - Kim; Dae-Kee ; et al.	2008-12-25
2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors App 20080319022 - Kim; Dae-Kee ; et al.	2008-12-25
2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors Grant 7,407,958 - Kim , et al. August 5, 2	2008-08-05
Factor VIII polypeptide Grant 7,041,635 - Kim , et al. May 9, 2	2006-05-09
2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors App 20050261299 - Kim, Dae-Kee ; et al.	2005-11-24
Factor VIII polypeptide App 20040147436 - Kim, Hun-Taek ; et al.	2004-07-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.